SOPHiA GENETICS SA

SOPH

Exchange: Nasdaq
Industry: Services-Computer Processing & Data Preparation
SEC CIK: 0001840706

SEC filings (opens in a new tab)

In the last 90 days, SOPHiA GENETICS SA insiders filed 2 open-market purchases and 27 sales; 72 institutions reported holding it in 13F filings for Q2 2026, worth $212.6M in total; Akre Capital Management is the only superinvestor holding it.

Key figures

Market capADS ratio not in SEC data: –
Insider buysLast 90 days, $278.4K in total: 2
Insider sellsLast 90 days, $1.62M in total: 27
13F holdersQ2 2026, +23 vs. previous quarter: 72
13F valueReported value at the end of Q2 2026: $212.6M
Superinvestors holdingAt the end of Q2 2026: 1

Price chart

Chart by TradingView (opens in a new tab)

Financials

See financial statements

From SEC filings, in USD.

Revenue, FY2025: $77.3M; +18.6% year over year
Net income, FY2025: -$79.0M; No comparable prior period
Free cash flow, FY2025: -$36.5M; No comparable prior period

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net loss for FY2025: $79.0M (102.2% of revenue).

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest: 1.15M; Shares sold short
Change: +148.0K; +14.8% vs. previous
Days to cover: 2.62; At average daily volume

Superinvestors holding SOPH, Q2 2026

Go to the superinvestors tab

1 superinvestor reports holding SOPHiA GENETICS SA on Form 13F. Percentages are the stock's share of each portfolio.

Akre Capital Management

Chuck Akre

0.4%

SOPHiA GENETICS SA's share of the portfolio

Shares: 3,719,140
Value: $21.5M

Latest insider trades

See all insider trades

Open-market purchases and sales by SOPHiA GENETICS SA insiders from Form 4, newest first.

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Nov 9, 2026 (view filing)4:06 PM ET	Nov 6	3 days	Cardoza GeorgeChief Financial Officer	PPurchase	+20.0K	$7.06	+$141.2K	+6.5%326.7K after
Nov 9, 2026 (view filing)4:05 PM ET	Nov 6	3 days	Muken RossChief Executive Officer	PPurchase	+20.0K	$6.86	+$137.2K	+3.0%680.4K after
Oct 14, 2026 (view filing)4:04 PM ET	Oct 12	2 days	Menu PhilippeChief Medical Officer	SSale	−5.00K	$7.26	−$36.3K	−2.5%196.0K after	10b5-1
Oct 14, 2026 (view filing)4:03 PM ET	Oct 13	1 day	Xu ZhenyuChief Scientific Officer	SSale	−4.00K	$7.18	−$28.7K	−0.7%541.5K after	10b5-1
Oct 14, 2026 (view filing)4:02 PM ET	Oct 12	2 days	Camblong JurgiExecutive Chairman	SSale	−8.50K	$7.26	−$61.7K	−0.3%3.39M after	10b5-1
Oct 7, 2026 (view filing)4:04 PM ET	Oct 5	2 days	Van Well DaanChief Legal Officer	SSale	−6.17K	$8.12	−$50.1K	−1.8%332.7K after	10b5-1
Oct 7, 2026 (view filing)4:04 PM ET	Oct 5	2 days	Valente ManuelaChief People Officer	SSale	−4.24K	$8.13	−$34.5K	−2.0%206.2K after	10b5-1
Oct 7, 2026 (view filing)4:04 PM ET	Oct 5	2 days	Verma AbhimanyuChief Technology Officer	SSale	−5.28K	$8.12	−$42.9K	−3.1%166.9K after	10b5-1
Oct 7, 2026 (view filing)4:04 PM ET	Oct 5	2 days	Puylaert KevinChief Sales Officer	SSale	−216	$8.04	−$1.74K	−0.1%147.7K after	2 lots
Oct 7, 2026 (view filing)4:04 PM ET	Oct 5	2 days	Cardoza GeorgeChief Financial Officer	SSale	−1.59K	$8.10	−$12.9K	−0.5%306.7K after	10b5-1

Top 10 13F holders, Q2 2026

See all 72 holders

The largest institutional positions in SOPHiA GENETICS SA at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding SOPH in Q2 2026
Institution	Shares	Value	% of portfolio	Change in shares	Action
Generation Investment Management LLP	6,789,560	$39.2M	0.38%	00.0%	Unchanged
AIGH Capital Management LLC	3,954,194	$22.8M	2.07%	+3,954,194	New
Akre Capital Management LLCSuperinvestorAkre Capital Management	3,719,140	$21.5M	0.42%	00.0%	Unchanged
Royce & Associates LP	3,381,736	$19.5M	0.16%	+1,565,424+86.2%	Added
Principal Financial Group Inc	2,364,256	$13.6M	0.01%	+955,014+67.8%	Added
Ameriprise Financial Inc	2,216,752	$12.8M	0.00%	+2,216,752	New
Banque Pictet & Cie SA	2,208,280	$12.7M	0.13%	00.0%	Unchanged
AWM Investment Company, Inc.	1,700,000	$9.81M	0.85%	+1,700,000	New
Soleus Capital Management, L.P.	1,565,000	$9.03M	0.31%	−285,000−15.4%	Reduced
Silvercrest Asset Management Group LLC	1,428,470	$8.24M	0.05%	+1,428,470	New

Holders of 5% or more of SOPH

See all 1 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of SOPHiA GENETICS SA.

Largest holders of SOPH from 13D and 13G filings
Holder	Latest form	Stake	Change	First filed	Latest filing	Filing
Akre Capital Management LLCSuperinvestorAkre Capital Management	13G	5.60%3.72M shares	New	Jun 27, 20251 filing	Jun 27, 2025	SEC